More about

Obesity

News
August 15, 2023
3 min read
Save

Growth hormone lowers liver fat for adults with obesity, steatotic liver disease

Growth hormone lowers liver fat for adults with obesity, steatotic liver disease

Adults with overweight or obesity and metabolic dysfunction-associated steatotic liver disease had a more than 5% reduction in liver fat at 6 months with growth hormone therapy, according to findings from a randomized controlled trial.

News
August 14, 2023
1 min read
Save

Top in cardiology: Wegovy cuts major events risk; AHA launches telehealth certification

Top in cardiology: Wegovy cuts major events risk; AHA launches telehealth certification

Injectable Wegovy 2.4 mg was associated with a 20% reduction in the risks for major adverse cardiovascular events among patients with overweight or obesity and established CVD, data show.

News
August 14, 2023
3 min read
Save

Odds of losing 5% or more body weight low in adults with overweight or obesity

Odds of losing 5% or more body weight low in adults with overweight or obesity

Adults with overweight or obesity in the U.S. have a one in 10 annual probability of achieving a 5% or greater weight loss, and the likelihood for weight loss increases with a higher initial BMI, according to study data.

News
August 08, 2023
2 min read
Save

Topline data show semaglutide cuts CV risk by 20%: SELECT

Topline data show semaglutide cuts CV risk by 20%: SELECT

Compared with placebo, injectable semaglutide 2.4 mg reduced risk for major adverse CV events by 20% for people with overweight or obesity and established CVD, according to topline data from the SELECT study.

News
August 07, 2023
2 min read
Save

AGA praises Treat and Reduce Obesity Act reintroduction to expand obesity care in Medicare

AGA praises Treat and Reduce Obesity Act reintroduction to expand obesity care in Medicare

The AGA applauded the reintroduction of the Treat and Reduce Obesity Act into the 118th Congress as this bill would expand Medicare coverage for screening and treatment of obesity by health care providers specializing in obesity care.

News
August 03, 2023
4 min read
Save

Weight management program improves asthma control, life quality in patients with obesity

Weight management program improves asthma control, life quality in patients with obesity

Among adults with difficult asthma and obesity, more improvement in asthma control and quality of life was found with a weight management program vs. usual care at week 16, according to results published in CHEST.

News
August 02, 2023
2 min read
Save

Obesity tied to chemotherapy-related cardiotoxicity in patients with breast cancer

Obesity tied to chemotherapy-related cardiotoxicity in patients with breast cancer

Overweight/obesity was independently prognostic of chemotherapy-related cardiotoxicity among patients undergoing treatment for breast cancer, according to a small study.

News
July 28, 2023
4 min read
Save

Q&A: Risk for small bowel obstruction is ‘not exclusively specific to bariatric surgery’

Q&A: Risk for small bowel obstruction is ‘not exclusively specific to bariatric surgery’

On July 13, the LA County medical examiner’s office reported that Lisa Marie Presley, singer-songwriter and child of Elvis Presley, died of a small bowel obstruction caused by scar tissue that developed after a previous bariatric surgery.

News
July 28, 2023
2 min read
Save

Bariatric surgery safe for people with HIV who are on ART

Bariatric surgery safe for people with HIV who are on ART

Bariatric surgery is safe for people with HIV whose viral load is being managed using ART, according to a study published in Clinical Infectious Diseases.

News
July 27, 2023
2 min read
Save

26% weight loss seen with tirzepatide in long-term SURMOUNT-3, SURMOUNT-4 trials

26% weight loss seen with tirzepatide in long-term SURMOUNT-3, SURMOUNT-4 trials

Adults with obesity who used tirzepatide for 72 weeks after lifestyle intervention or continuously for 88 weeks achieved a mean weight loss of 26%, according to topline results from two SURMOUNT trials.

View more